Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
43,000
Employees43,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
43,000
Employees43,000

LLY Key Statistics

Market cap
720.29B
Market cap720.29B
Price-Earnings ratio
130.59
Price-Earnings ratio130.59
Dividend yield
0.60%
Dividend yield0.60%
Average volume
3.24M
Average volume3.24M
High today
$763.25
High today$763.25
Low today
$751.66
Low today$751.66
Open price
$762.25
Open price$762.25
Volume
2.72M
Volume2.72M
52 Week high
$794.47
52 Week high$794.47
52 Week low
$309.20
52 Week low$309.20

LLY News

Yahoo Finance 13h
M&A on the horizon? Viking Therapeutics extends rally - Yahoo Finance

Shares of Viking Therapeutics (VKTX) continued surging Wednesday after the company reported positive mid-stage trial data for its experimental obesity drug. BTI...

M&A on the horizon? Viking Therapeutics extends rally - Yahoo Finance
Benzinga 18h
Viking Therapeutics' Weight Loss Study Data Outperformed Novo Nordisk, Eli Lilly Studies, Analysts Say

Loading... Loading... Viking Therapeutics Inc VKTX recently released top-line results from a successful Phase 2 weight loss trial. Patients receiving VK2735 d...

Viking Therapeutics' Weight Loss Study Data Outperformed Novo Nordisk, Eli Lilly Studies, Analysts Say
Benzinga 19h
Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss

Loading... Loading... Eli Lilly And Co’s LLY CEO, David Ricks, shared the pharmaceutical giant’s plans to introduce its obesity drug, tirzepatide, in India as...

Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss

Analyst ratings

71%

of 28 ratings
Buy
71.4%
Hold
17.9%
Sell
10.7%

More LLY News

Yahoo Finance 20h
The Zacks Analyst Blog Highlights Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic - Yahoo Finance

For Immediate Release Chicago, IL – February 28, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Researc...

The Zacks Analyst Blog Highlights Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic - Yahoo Finance
Bloomberg 22h
Berkshire and Lilly Race to Shake Tech’s Grip on Trillion-Dollar Club

(Bloomberg) -- Big Tech stocks created, and have so far dominated, the trillion-dollar club in the US. For the first time, there’s a race brewing for an outside...

Berkshire and Lilly Race to Shake Tech’s Grip on Trillion-Dollar Club
Benzinga 1d
Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag'

Loading... Loading... During Tuesday’s CNBC Investing Club Morning Meeting, U.S. stocks exhibited mixed performance, prompting a closer look at prevailing mark...

Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag'
Quartz 1d
The Novo Nordisk-Eli Lilly weight loss drug duopoly is facing some hot competitors - Quartz

Good morning, Quartz readers! Here’s what you need to know The Novo Nordisk-Eli Lilly weight loss drug duopoly is facing some hot competitors. The stocks of...

The Novo Nordisk-Eli Lilly weight loss drug duopoly is facing some hot competitors - Quartz
Yahoo Finance 1d
Why Novo Nordisk and Eli Lilly Stocks Slipped Today - Yahoo Finance

The arrival of a potential new rival in an important product category dinged the share prices of pharmaceutical companies Novo Nordisk (NYSE: NVO) and Eli Lilly...

Why Novo Nordisk and Eli Lilly Stocks Slipped Today - Yahoo Finance
Benzinga 2d
Are Nvidia, Eli Lilly, AMD's High Equity Valuations In Peril From Higher Rates?

Loading... Loading... Higher long-term rates typically matter a lot to equity valuations. However, according to DataTrek, today’s mega-cap stocks are likely to...

Are Nvidia, Eli Lilly, AMD's High Equity Valuations In Peril From Higher Rates?
CNBC 2d
Calls of the Day: Some bullish calls on Netflix, Eli Lilly, General Electric and Snowflake - CNBC

In this video Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email Calls of the Day: Some bullish cal...

Calls of the Day: Some bullish calls on Netflix, Eli Lilly, General Electric and Snowflake - CNBC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.